Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Inogen Inc | 3,549,320 | reported | 04 Nov 2014 | tx 17+6,077,927−7,399,623 |
| Corvus Pharmaceuticals, Inc. | 3,224,046 | reported | 12 May 2016 | tx 6+3,224,046−2,487,380 |
| CoLucid Pharmaceuticals, Inc. | 3,156,563 | reported | 09 Sept 2016 | tx 4+3,156,563−1,756,563 |
| ANAPTYSBIO, INC | 3,033,504 | reported | 31 Jan 2017 | tx 11+3,033,504−3,019,066 |
| Otonomy, Inc. | 2,175,025 | reported | 19 Aug 2014 | tx 10+2,175,025−1,987,460 |
| Flexion Therapeutics Inc | 2,133,131 | reported | 22 Jun 2015 | tx 7+2,283,131−9,018,393 |
| iRhythm Holdings, Inc. | 2,024,448 | reported | 25 Oct 2016 | tx 3+2,107,449−2,007,449 |
| Regado Biosciences Inc | 1,875,905 | reported | 13 Jul 2016 | tx 17+838,041−820,500 |
| LPATH INC | 1,351,972 | reported | 11 May 2017 | tx 2−105,000 |
| Ra Pharmaceuticals, Inc. | 924,970 | reported | 31 Oct 2016 | tx 5+2,031,562−1,785,408 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Jun 2017 | SALE | REATA PHARMACEUTICALS INC | 49,611 | 25.03 USD | |
| 13 Jun 2017 | SALE | REATA PHARMACEUTICALS INC | 11,389 | 25.47 USD | |
| 12 Jun 2017 | SALE | REATA PHARMACEUTICALS INC | 90,303 | 25.28 USD | |
| 09 Jun 2017 | SALE | REATA PHARMACEUTICALS INC | 2,200 | 25.89 USD | |
| 08 Jun 2017 | SALE | REATA PHARMACEUTICALS INC | 130,000 | 26.00 USD | |
| 07 Jun 2017 | SALE | REATA PHARMACEUTICALS INC | 2,000 | 28.04 USD | |
| 06 Jun 2017 | SALE | REATA PHARMACEUTICALS INC | 64,170 | 28.09 USD | |
| 05 Jun 2017 | SALE | REATA PHARMACEUTICALS INC | 23,327 | 28.67 USD | |
| 10 May 2017 | SALE | LPATH INC | 1,500 | 5.74 USD | |
| 11 May 2017 | SALE | LPATH INC | 103,500 | 5.62 USD | |
| 31 Jan 2017 | CONVERSION | ANAPTYSBIO, INC | 1,428,571 | — | |
| 31 Jan 2017 | CONVERSION | ANAPTYSBIO, INC | 486,820 | — | |
| 31 Jan 2017 | CONVERSION | ANAPTYSBIO, INC | 312,986 | — | |
| 31 Jan 2017 | CONVERSION | ANAPTYSBIO, INC | 673,454 | — | |
| 31 Jan 2017 | EXERCISE | ANAPTYSBIO, INC | 81,673 | — | |
| 31 Jan 2017 | PURCHASE | ANAPTYSBIO, INC | 50,000 | 15.00 USD | anomaly |
| 31 Jan 2017 | EXERCISE | ANAPTYSBIO, INC | 117,235 | 0.00 USD | deriv |
| 31 Jan 2017 | CONVERSION | ANAPTYSBIO, INC | 312,986 | 0.00 USD | deriv |
| 31 Jan 2017 | CONVERSION | ANAPTYSBIO, INC | 1,428,571 | 0.00 USD | deriv |
| 31 Jan 2017 | CONVERSION | ANAPTYSBIO, INC | 673,454 | 0.00 USD | deriv |
| 31 Jan 2017 | CONVERSION | ANAPTYSBIO, INC | 486,820 | 0.00 USD | deriv |
| 15 Dec 2016 | SALE | Ophthotech Corp. | 1,405,487 | 4.72 USD | |
| 14 Dec 2016 | SALE | Ophthotech Corp. | 2,205,000 | 4.97 USD | |
| 31 Oct 2016 | PURCHASE | Ra Pharmaceuticals, Inc. | 246,154 | 13.00 USD | anomaly |
| 31 Oct 2016 | CONVERSION | Ra Pharmaceuticals, Inc. | 860,438 | — |
3 purchases reported after at least 12 months of silence — most recent on 30 Sept 2013.